Eyüpoğlu, N. D., Çınar, O. E., Aksu, S., Büyükaşık, Y., Sayınalp, N., Demiroğlu, H., Göker, H., Özcebe, O. İ. and Haznedaroğlu, İ. C. (2022) “Event-free Survival in Patients with Chronic Myeloid Leukemia Receiving Front-line Imatinib Mesylate”, Acta Medica, 53(3), pp. 277–283. doi: 10.32552/2022.ActaMedica.745.